Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    1.

    Towards a genetic AIDS vaccine.

    Bordería AV, Berkhout B.

    Retrovirology. 2009 Oct 16;6:93.

    PMID:
    19835599
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys.

    Johnson PR, Schnepp BC, Zhang J, Connell MJ, Greene SM, Yuste E, Desrosiers RC, Clark KR.

    Nat Med. 2009 Aug;15(8):901-6. Epub 2009 May 17.

    PMID:
    19448633
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

    Benson J, Chougnet C, Robert-Guroff M, Montefiori D, Markham P, Shearer G, Gallo RC, Cranage M, Paoletti E, Limbach K, Venzon D, Tartaglia J, Franchini G.

    J Virol. 1998 May;72(5):4170-82.

    PMID:
    9557706
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Post-infection immunodeficiency virus control by neutralizing antibodies.

    Yamamoto H, Kawada M, Takeda A, Igarashi H, Matano T.

    PLoS One. 2007 Jun 20;2(6):e540.

    PMID:
    17579714
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.

    Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.

    J Virol. 2005 Oct;79(19):12321-31.

    PMID:
    16160159
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.

    Quinnan GV Jr, Yu XF, Lewis MG, Zhang PF, Sutter G, Silvera P, Dong M, Choudhary A, Sarkis PT, Bouma P, Zhang Z, Montefiori DC, Vancott TC, Broder CC.

    J Virol. 2005 Mar;79(6):3358-69.

    PMID:
    15731230
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.

    Cole KS, Rowles JL, Jagerski BA, Murphey-Corb M, Unangst T, Clements JE, Robinson J, Wyand MS, Desrosiers RC, Montelaro RC.

    J Virol. 1997 Jul;71(7):5069-79.

    PMID:
    9188572
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy.

    Shimada M, Wang HB, Kondo A, Xu XP, Yoshida A, Shinoda K, Ura T, Mizuguchi H, Klinman D, Luo JL, Bai H, Okuda K.

    Gene Ther. 2009 Feb;16(2):218-28. Epub 2008 Oct 16.

    PMID:
    18923453
    [PubMed - indexed for MEDLINE]
    10.

    Use of simian immunodeficiency virus for vaccine research.

    Daniel MD, Sehgal PK, Kodama T, Wyand MS, Ringler DJ, King NW, Schmidt DK, Troup CD, Desrosiers RC.

    J Med Primatol. 1990;19(3-4):395-9.

    PMID:
    2231691
    [PubMed - indexed for MEDLINE]
    11.

    Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.

    Kumar A, Mukherjee S, Shen J, Buch S, Li Z, Adany I, Liu Z, Zhuge W, Piatak M Jr, Lifson J, McClure H, Narayan O.

    Virology. 2002 Sep 30;301(2):189-205.

    PMID:
    12359422
    [PubMed - indexed for MEDLINE]
    12.

    Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.

    Schlienger K, Montefiori DC, Mancini M, Rivière Y, Tiollais P, Michel ML.

    J Virol. 1994 Oct;68(10):6578-88.

    PMID:
    7521918
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.

    Clements JE, Montelaro RC, Zink MC, Amedee AM, Miller S, Trichel AM, Jagerski B, Hauer D, Martin LN, Bohm RP, et al.

    J Virol. 1995 May;69(5):2737-44.

    PMID:
    7707496
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.

    Mossman SP, Bex F, Berglund P, Arthos J, O'Neil SP, Riley D, Maul DH, Bruck C, Momin P, Burny A, Fultz PN, Mullins JI, Liljeström P, Hoover EA.

    J Virol. 1996 Mar;70(3):1953-60.

    PMID:
    8627721
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Neutralizing antibodies in SIV control: co-impact with T cells.

    Yamamoto H, Matano T.

    Vaccine. 2010 May 26;28 Suppl 2:B13-7.

    PMID:
    20510737
    [PubMed - indexed for MEDLINE]
    16.

    Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile.

    Haigwood NL, Watson A, Sutton WF, McClure J, Lewis A, Ranchalis J, Travis B, Voss G, Letvin NL, Hu SL, Hirsch VM, Johnson PR.

    Immunol Lett. 1996 Jun;51(1-2):107-14.

    PMID:
    8811353
    [PubMed - indexed for MEDLINE]
    17.

    Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

    Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA.

    Nature. 2002 Jan 17;415(6869):331-5.

    PMID:
    11797011
    [PubMed - indexed for MEDLINE]
    18.

    Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.

    Nehete PN, Chitta S, Hossain MM, Hill L, Bernacky BJ, Baze W, Arlinghaus RB, Sastry KJ.

    Vaccine. 2001 Dec 12;20(5-6):813-25.

    PMID:
    11738745
    [PubMed - indexed for MEDLINE]
    19.

    Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).

    Kumar A, Lifson JD, Li Z, Jia F, Mukherjee S, Adany I, Liu Z, Piatak M, Sheffer D, McClure HM, Narayan O.

    Virology. 2001 Jan 5;279(1):241-56.

    PMID:
    11145906
    [PubMed - indexed for MEDLINE]
    20.

    Passive immunization of rhesus macaques against SIV infection and disease.

    Gardner M, Rosenthal A, Jennings M, Yee J, Antipa L, Robinson E Jr.

    AIDS Res Hum Retroviruses. 1995 Jul;11(7):843-54.

    PMID:
    7546912
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk